MENU
IMNM
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION

Immunome (IMNM) Ownership - Who owns Immunome?

Immunome Inc is a biopharmaceutical company... Show more

Profile

Industry
N/A
Address
18702 N. Creek Parkway
Phone
+1 610 321-3700
Employees
55
Web
https://www.immunome.com

Details

Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
2.22B
P/E Ratio
N/A
Total Cash
272.64M
Projected Growth
N/A
Total Debt
4.01M
Revenue
9.68M
Risk (Beta)
4.32
Dividend Yield
N/A
Total Cash/Share
2.47
Total Debt/Equity
N/A
Revenue/Share
0.12 USD as % of share price

Fundamentals

IMNM
Capitalization
2.22B
P/E Ratio
N/A
Risk (Beta)
4.32
Dividend Yield
N/A
Total Cash
273M
Total Cash/Share
2.47
Total Debt
4.01M
Total Debt/Equity
N/A
Projected Growth (PEG Ratio)
N/A
Revenue/Share (as % of the share price)
0.12%
Revenue
9.68M
ROE
N/A
Book Value
264M
P/B Ratio
8.42
Cash Flow
N/A
Earnings
-2.96
Average Daily Volume YTD
N/A
Common Shares Outstanding - Security Level
9K
Current Ratio
8.90
Current Revenue Per Employee
25903.23
Dividends Per Share - Security
N/A
EBITDA
-231.45M
Float
N/A
Float - Current
N/A
Gross Income Margin
N/A
Revenue To Assets
-80.08
Shares Held By Institutions
1.64B
Shares Outstanding - Current
110M
Total Liabilities
35.5M
Total Volume MTD
N/A
Value
N/A
Gain YTD
-6.238
View a ticker or compare two or three
IMNM
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I.Advisor
published price charts
These past five trading days, the stock lost 0.00% with an average daily volume of 0 shares traded.The stock tracked a drawdown of 0% for this period. IMNM showed earnings on November 07, 2025. You can read more about the earnings report here.
A.I. Advisor
published General Information

General Information

Industry Biotechnology

Profile
Fundamentals
Details
Industry
N/A
Address
18702 N. Creek Parkway
Phone
+1 610 321-3700
Employees
55
Web
https://www.immunome.com